An interventional study of WYSH Web Application in Hypospadias, sponsored by University of Wisconsin, Madison. Recruiting at 1 site in United States. Open to male participants aged 5 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Hypospadias with a site in United States — 4 open to participants now, 5 under way, none of them phase 3. Hypospadias · United States.
Among the 20 studies in Hypospadias with a site in United States, this one is the 15th largest by planned enrollment of the 18 interventional ones that give a count, is one of 3 that started in 2025, is one of 14 with no phase, and was the 19th registered.
124 studies on the registry are indexed under Hypospadias; 35 are open to participants now.
Browse Hypospadias studies →4 of the 20 studies in Hypospadias with a site in United States are open now. Recruiting first, the newest first:
Sarah Schlegel · Sites in United States
Ages 18+ · Healthy volunteers
University of North Carolina, Chapel Hill · Sites in United States
Boston Children's Hospital · Sites in United States
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 20 Hypospadias studies recruiting now, 4 (20%) set no upper age limit and 16 (80%) stop at 75 or younger; 18 take children under 18; 3 take healthy volunteers.
This study: 5 Years to 65 Years · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 70 across 98 interventional studies indexed under Hypospadias.
Median enrollment 67 across the 18 interventional studies, 237 across the 2 observational. Of the 13 that completed or were terminated, 4 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 20 has an industry lead sponsor. The 10 most frequent:
University of Wisconsin, Madison is the lead sponsor of 1,190 studies on the registry; 181 are open to participants now.
Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.
University of Wisconsin, Madison has 1 study filed under Hypospadias — fewer than ten, so there is no comparison to draw.
2 of the studies in Hypospadias with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06989593Sarah SchlegelBreaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions | 2026-11 |
| NCT06966375University of Wisconsin, MadisonWorldwide Yearly Screening for Hypospadias | 2027-04 |
Add all 2 to your calendar (.ics) → With an account.
Among the 20 studies in Hypospadias with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to recruit approximately 20 male participants who have a history of repaired hypospadias to test the feasibility and acceptability of the Care Planning Tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Web Application.
Several studies show that patients who undergo hypospadias repair report significant functional and psychosexual issues in adolescence or adulthood (in more than 50% of cases). The Care Planning tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Web Application, developed using expert level consensus from a Delphi Measure including stakeholders (psychologists, urologists, endocrinologists, patients/families), is designed to support the functional and psychosexual health of male youth and adults treated for hypospadias, to support their physical and mental health after repair.
This is a pilot study of the WYSH intervention to access its feasibility and acceptability.
[Potential participants can enroll at their local clinic.]
The criteria were revised on the registry on Oct 1, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age groups targeted, based on recommended standards for user experience data from pilot studies:
Exclusion Criteria:
-
* 3-5 Males, age 0-4 (with parental consent) * 3-5 Males, age 5-10 (with parental consent and child assent) * 3-5 Males, age 11-15 (with parental consent and child assent) * 3-5 Males, age 16-20 (with parent consent, child assent until age 18) * 3-5 Males, age 21-65
Other: WYSH Web Application
Worldwide Yearly Screening for Hypospadias (WYSH) Web Application
Feasibility: Participant Count to Summarize answers of the Care Planning Tool
The Care Planning Tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Application is a survey containing forty-eight questions regarding possible complications for participating patients (Subsections of penile function, voiding, sexual health, social functioning, psychological health, and doctor-patient communication). These questions will be completed by patients using a five point scale - "Never," "Rarely," "Sometimes," "Often," and "Always" - to populate a Care Plan highlighting areas of concern (with a threshold of two or more metrics above a "Sometimes" response).
Time frame: Baseline, 3 weeks, 3 months
Acceptability: User Centered Metrics
Participating patients will complete a survey regarding the System Usability to determine ease of functionality throughout the application. This survey contains a scale for participants to graph their response from "Very Difficult" to "Very Easy" following the eleven questions of task completion. Additionally, there is a space provided for open-ended feedback.
Time frame: Baseline, 3 weeks, 3 months
Acceptability: Cognitive Debriefing Measures
A team from the Wisconsin Surgical Outcomes Research Program (WiSOR) will complete a Cognitive Debriefing Interview with participating patients to assist in determining validation and comprehension. This interview consists of seven open-ended questions regarding participants' thought processes to provide an insight into areas of improvement for the application. Answers will be coded and themes summarized by participant count.
Time frame: Baseline, 3 weeks, 3 months
Feasibility: System Usability Testing
The Center for User Experience will conduct masked System Usability Testing to provide user-based information on how to improve the online experience for young males and their caregivers and adult males. Usability will be assessed with a level of success rating from "Failure," "Success with a major issue," "Success with a minor issue," and "Complete Success," where minor or major issues and time taken are observed as the participating patient is completing the System Usability Scale.
Time frame: Baseline, 3 weeks, 3 months
Provider Acceptability: Usability Scale
Participating UW Clinicians will rate the recommendations received in each care plan from patients in a separate usability scale (Provider Acceptability) to improve the ability for continuity of care. Providers will complete a survey of questions surrounding format, output, and utility from "Strongly Disagree" to "Strongly Agree." Additionally, there is a space provided for feedback.
Time frame: Data collected after participating patient completes questionnaire, up to approximately 3 months.
Plan to share: Yes — Individual participant data collected during pilot testing, after deidentification, will be accessible in the form of text, tables, publications, figures, etc. to disseminate efficacy of the Care Planning tool within the application.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Deidentified individual personal data and supporting information will be made available immediately after publication.
No publications or documents are linked to this record.
Started Jul 2025 (actual). Primary completion is estimated for Apr 2027, 21 months after the start.
Of 60 non-industry interventional studies with no phase under Hypospadias, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 39. This study's planned 21 months is above that.
Counting every sponsor, half of 60 studies reached it within 15 months; a quarter within 8 and three quarters within 39.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Nov 2026 → Apr 2027 and completion Nov 2026 → Apr 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Wisconsin, Madison →